2.5.1 Vasodilator antihypertensive drugs
Ambrisentan
Ambrisentan 10mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Ambrisentan 5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Bosentan
Bosentan 125mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Bosentan 62.5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Hydralazine
Hydralazine 20mg powder for solution for injection ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Hypertension |
Hydralazine 25mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Heart failure |
Hydralazine 50mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Heart failure |
Iloprost
Iloprost 10micrograms/1ml nebuliser liquid ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Iloprost 20micrograms/1ml nebuliser liquid ampoules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Macitentan
Macitentan 10mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Riociguat
Riociguat 1.5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Riociguat 1mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Riociguat 2.5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Riociguat 2mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Selexipag
Selexipag 1.2mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Selexipag 1.4mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Selexipag 1.6mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Selexipag 1mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Selexipag 200microgram tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Selexipag 400microgram tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Selexipag 600microgram tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
Selexipag 800microgram tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |